Treatment Journeys

Letrozole success rates

Letrozole success rates

Letrozole success rates

·

6 min read


Medical information, not personal medical advice

Letrozole should only be used under the direction of a qualified fertility clinician. Your diagnosis, age, ovarian response, partner or donor sperm results, tubal health and treatment setting all affect your individual chance of success.

Letrozole success rates by age

Your complete evidence-based guide to ovulation induction, PCOS and pregnancy

Trying to conceive can be exciting, emotional and sometimes overwhelming. If your fertility specialist has recommended letrozole, you are probably wondering:

  • Will letrozole help me ovulate?

  • What are my chances of getting pregnant?

  • Does my age affect success?

  • Is letrozole better than Clomid?

  • How many cycles should I try before considering IVF?

These are some of the most common questions we hear at Oocyt.

The good news is that letrozole has become one of the most effective first-line fertility treatments for women who are not ovulating regularly, particularly those living with polycystic ovary syndrome (PCOS).

However, one important point is often misunderstood.

Many websites quote fixed pregnancy percentages based purely on age. In reality, fertility is far more personal than that.

Your chances of pregnancy depend on several factors working together, including:

  • Age

  • Egg quality

  • Ovarian reserve

  • Ovulation

  • Fallopian tubes

  • Sperm quality

  • Uterine health

  • Overall reproductive health

Rather than focusing on one number, understanding the complete picture helps you make informed decisions about your fertility journey.

This guide explains what letrozole does, who it helps, how age influences treatment, what the latest research tells us and how you can maximise your chances of success.

At a glance

Quick fact

What it means

Medication

Letrozole (Femara®)

Medication type

Aromatase inhibitor

Primary purpose

Ovulation induction

Best-supported use

Anovulatory infertility due to PCOS

Treatment length

Usually five days each menstrual cycle

Typical starting dose

2.5 mg daily, according to the prescribing clinic

Monitoring

Ultrasound scans and/or hormone blood tests

Often combined with

Timed intercourse or IUI

Oocyt clinical insight

Every fertility journey is unique. Two women of the same age can have very different chances of pregnancy depending on ovarian reserve, medical history and fertility diagnosis. Personalised assessment is more useful than relying on averages found online.

Why trust this guide?

The internet is full of articles quoting exact success rates for letrozole. Unfortunately, many figures are taken out of context, use different definitions of success or are based on older studies.

At Oocyt, we believe patients deserve accurate, evidence-based information rather than unrealistic promises. This guide draws on:

  • The International Evidence-Based Guideline for PCOS (2023)

  • NICE fertility guidance

  • The American Society for Reproductive Medicine (ASRM)

  • The European Society of Human Reproduction and Embryology (ESHRE)

  • Landmark clinical trials published in the New England Journal of Medicine

  • Cochrane systematic reviews

Rather than focusing on isolated statistics, we explain what the evidence can and cannot tell you.

Quick answer

Does letrozole really work?

Yes - for the right patient.

Letrozole is considered one of the most effective medications for inducing ovulation in women who do not ovulate regularly, especially those with PCOS.

Research has shown that letrozole can:

  • Improve ovulation rates

  • Increase pregnancy rates

  • Improve live-birth rates

  • Produce a lower multiple-pregnancy rate than Clomid in women with PCOS

One of the largest fertility studies found that approximately 27.5% of women with PCOS achieved a live birth after up to five letrozole treatment cycles, compared with 19.1% treated with clomiphene (Clomid). This was a cumulative result across several cycles, not a personalised chance per cycle or for a particular age. [2]


How to read this result

The 27.5% figure does not mean your chance of pregnancy is exactly 27.5%. It demonstrates that letrozole is effective when prescribed for the right indication and used across a defined course of treatment.

What is letrozole?

Originally developed to treat hormone-sensitive breast cancer, letrozole is now widely used in fertility medicine because it can help stimulate ovulation.

Although it was not originally licensed specifically for fertility treatment, it is commonly prescribed by fertility specialists around the world and is recommended in international clinical guidance for women with anovulatory PCOS. In UK fertility practice, its use for ovulation induction is generally off-label.

Today, it is considered the first-line ovulation-induction medication for many women with irregular or absent ovulation. [1]

How does letrozole work?

To understand letrozole, it helps to understand how ovulation normally occurs. Each month, the brain communicates with the ovaries using hormones. One of the most important is follicle-stimulating hormone (FSH), which encourages small follicles inside the ovary to grow.

Usually, one follicle becomes dominant and releases an egg during ovulation. Women with PCOS may have many small follicles but struggle to develop one mature follicle capable of releasing an egg.

Letrozole temporarily lowers oestrogen production. The brain detects this reduction and responds by producing more FSH. This stronger signal may help the ovary mature a dominant follicle and increase the chance of ovulation.


Oocyt expert tip

Letrozole does not create eggs. A person is born with their lifetime supply of eggs. The medication supports the development and release of an egg that may not otherwise have matured during that cycle.


Who is letrozole most suitable for?

A fertility specialist may recommend letrozole for:

  • PCOS

  • Irregular menstrual cycles

  • Absent ovulation (anovulation)

  • Infrequent ovulation (oligo-ovulation)

  • Previous unsuccessful Clomid treatment

  • Selected cases of unexplained infertility

  • Ovulation induction before IUI

  • Other mild ovulatory disorders after assessment

It is not suitable for everyone. People with blocked fallopian tubes, severe male-factor infertility or certain other fertility conditions may benefit from different treatment options, including IVF.

Did you know?

PCOS affects around one in ten women of reproductive age and is one of the most common causes of ovulatory infertility. It is also one of the most treatable causes when the diagnosis and wider fertility assessment are clear.

Why has letrozole replaced Clomid for many women?

For many years, Clomid (clomiphene citrate) was the standard treatment for ovulation induction. It remains effective, but research over the past decade has shown that letrozole offers important advantages for many women with PCOS.

Letrozole

Clomid

First-line treatment for anovulatory PCOS

Previously used as first-line treatment

Higher live-birth rate in the landmark PCOS trial

Lower live-birth rate in the same trial

Lower twin-pregnancy rate in the trial

A somewhat higher twin-pregnancy rate

Usually less effect on the uterine lining

May thin the uterine lining in some patients

Usually less effect on cervical mucus

Can reduce fertile cervical mucus

Often well tolerated

More anti-oestrogenic effects for some patients

Oocyt clinical insight

Choosing a fertility medication is not about selecting the newest option. It is about matching treatment to your diagnosis, medical history, fertility goals and response. A personalised plan offers more useful guidance than a generic success rate.

Coming up next

The next sections of this cornerstone guide will cover:

Part 2

Letrozole success rates by age

Part 3

Why age matters

Part 4

The role of AMH and ovarian reserve

Part 5

Why ovulation does not always lead to pregnancy

Part 6

Common mistakes when interpreting fertility statistics

References

1. Teede, H.J. et al. (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Journal of Endocrinology, 189(2), G43-G64.

2. Legro, R.S. et al. (2014) Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 371, 119-129.

3. Franik, S. et al. (2022) Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, Issue 9.

4. NICE (2026) Fertility problems: assessment and treatment. NICE guideline NG257.

5. Cambridge University Hospitals NHS Foundation Trust (accessed July 2026) Using letrozole tablet (Femara®) for ovulation induction.

Editorial disclaimer

Oocyt provides fertility education, guidance and support services only. We do not provide medical advice, diagnosis or treatment. Medical decisions should be made with licensed healthcare professionals and your treating clinic.

Start with Confidence

Considering fertility treatment? Let Oocyt be your guide.

Caring. Creating. Innovation

ABOUT US

Oocyt is a global fertility concierge service specializing in IVF coordination and international fertility travel for individuals and couples seeking parenthood.

DISCLAIMER NOTICE

Oocyt provides fertility education, guidance, and support services only. We do not offer medical advice, diagnosis, or treatment. Engaging with Oocyt does not create a clinician–patient relationship. All medical decisions and treatments must be made with licensed healthcare providers and treating clinics.

SOCIAL MEDIA

Start with Confidence

Considering fertility treatment? Let Oocyt be your guide.

Caring. Creating. Innovation

ABOUT US

Oocyt is a global fertility concierge service specializing in IVF coordination and international fertility travel for individuals and couples seeking parenthood.

DISCLAIMER NOTICE

Oocyt provides fertility education, guidance, and support services only. We do not offer medical advice, diagnosis, or treatment. Engaging with Oocyt does not create a clinician–patient relationship. All medical decisions and treatments must be made with licensed healthcare providers and treating clinics.

SOCIAL MEDIA

Start with Confidence

Considering fertility treatment? Let Oocyt be your guide.

Caring. Creating. Innovation

ABOUT US

Oocyt is a global fertility concierge service specializing in IVF coordination and international fertility travel for individuals and couples seeking parenthood.

DISCLAIMER NOTICE

Oocyt provides fertility education, guidance, and support services only. We do not offer medical advice, diagnosis, or treatment. Engaging with Oocyt does not create a clinician–patient relationship. All medical decisions and treatments must be made with licensed healthcare providers and treating clinics.

SOCIAL MEDIA